Global Hemostats Market Size Study & Forecast, by Product (Active Hemostats, Passive Hemostats, Combination Hemostats, and Others), Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery and Others)

The Global Hemostats Market is valued at approximately USD 4.75 billion in 2024 and is anticipated to expand at a CAGR of more than 7.90% during the forecast period 2025-2035. Hemostats, designed to control bleeding during surgical interventions, have become indispensable across a broad spectrum of procedures ranging from trauma and cardiovascular operations to neurosurgery and orthopedic interventions. These agents, which can be mechanical, active, or combination-based, play a crucial role in ensuring surgical precision, reducing blood loss, and improving patient outcomes. The market’s expansion is fundamentally being driven by rising surgical volumes globally, increased prevalence of trauma cases, and a higher incidence of chronic conditions requiring surgical interventions. Additionally, advancements in surgical techniques and innovations in hemostatic product formulations have amplified adoption across hospitals, ambulatory surgical centers, and military medical units.

The surging demand for minimally invasive procedures, which often require precise bleeding management, has significantly accelerated the uptake of hemostats worldwide. For instance, cardiovascular surgeries, orthopedic implants, and cosmetic reconstructions all necessitate reliable hemostatic agents for enhanced safety and efficiency. According to the World Health Organization, non-communicable diseases such as cardiovascular ailments remain the leading cause of mortality worldwide, fueling the number of surgeries that inherently depend on hemostatic solutions. Moreover, technological progress enabling faster clotting mechanisms, reduced infection risk, and biocompatible formulations are opening new avenues for adoption. However, despite the strong growth trajectory, high product costs and stringent regulatory frameworks around surgical consumables could act as deterrents during the forecast horizon.

From a regional perspective, North America dominated the global market in 2025, attributable to its advanced healthcare infrastructure, rising surgical admissions, strong reimbursement structures, and the presence of leading market players with robust product portfolios. The region’s well-established cardiovascular and orthopedic surgery volumes continue to reinforce the demand for hemostatic agents. Meanwhile, Asia Pacific is poised to exhibit the fastest growth through 2035, bolstered by rapid urbanization, an aging population, expanding healthcare expenditure, and increased surgical procedures in countries such as China and India. Europe also maintains a strong foothold with high adoption in trauma and cardiovascular surgeries, driven by rising incidences of chronic illnesses and government-backed healthcare investments. Latin America and the Middle East & Africa are witnessing emerging opportunities as awareness of advanced surgical consumables increases and healthcare infrastructure gradually strengthens.

Major market players included in this report are:
• Johnson & Johnson (Ethicon)
• Baxter International Inc.
• Pfizer Inc.
• B. Braun Melsungen AG
• Medtronic plc
• CSL Behring
• CryoLife, Inc.
• Teleflex Incorporated
• Stryker Corporation
• Mallinckrodt Pharmaceuticals
• Marine Polymer Technologies, Inc.
• Hemostasis LLC
• Integra LifeSciences
• Z-Medica, LLC
• Smith & Nephew plc

Global Hemostats Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Active Hemostats
• Passive Hemostats
• Combination Hemostats
• Others

By Application:
• Trauma
• Cardiovascular Surgery
• General Surgery
• Plastic Surgery
• Orthopedic Surgery
• Neurosurgery
• Others

By End-User:
• Hospitals & ASCs
• Tactical Combat Casualty Care Centers
• Others

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more